Daniel Torrecilla, PhD

Research Group: MeMoEn (Molecular Mechanisms of Disease)

Associate Investigator

 

Contact
Research Center for Molecular Medicine and Chronic Diseases (CIMUS)
Avda. Barcelona s/n, Campus Vida, 15706, Santiago de Compostela
University of Santiago de Compostela  
Phone: +34 881 815415
 
Biosketch

After Biology and Biotechnology degrees and training in biotechnology companies, Daniel developed his PhD in Molecular Medicine at University of Santiago de Compostela (Galician Group of Oncology Research, Department of Physiology, School of Medicine). He worked in the oncology field, learning about cancer biology, genomics and new target discovery and in the development of personalized nanotechnology-based treatments for some types of cancer.

He moved to the regenerative medicine field during his postdoctoral work at Hospital for Special Surgery (New York, USA), in the Bone Cell Biology and Molecular Imaging Lab, working with stem cells and differentiation strategies combined with in vivo surgical procedures and molecular imaging for deciphering molecular mechanisms of rheumatology and orthopedics problems.

After returning, he has worked in the Galician Public Foundation for Genomic Medicine at Santiago de Compostela University Hospital (molecular diagnostics and functional genomics), in the University of A Coruña, in the Innopharma Pharmacogenomic Platform at CIMUS Research Center (early drug discovery), in Kaertor Foundation (innovation incubation for drug discovery) and with stays in other institutions as the International Iberian Nanotechnology Laboratory-INL (Braga, Portugal). Currently, he is working as Associate Investigator in the Research Group of Molecular Mechanisms of Disease (MeMoEn), University of Santiago de Compostela, interested in biotechnology application for oncology, regenerative medicine and rare diseases and collaborating in the research group management and consolidation. He is also external project evaluator of different institutions and external reviewer for some specialized journals.

With experience in different universities, hospitals and pharma-biotech companies, Daniel mixes his background in molecular and cell biology, -omics technologies, in vivo animal models and drug discovery with training in innovation, tech transfer and project management. He supports science for biomedical innovation, believes in public-private partnerships and collaboration for strengthening of the biotechnology ecosystem, and is concerned about education and training for the next generation of biotechnologists.

 
Main participated initiatives

- InveNNta: Innovation in Nanomedicine: support for the employment and the socio-economic development in the new production system of the Euro region

- Innopharma Pharmacogenomic Platform

- Joint Research Unit USC-Esteve Laboratories

- REGID: Galician Network for Medicines R&D

- REDEFAR: Spanish Network of Excellence for Drug Discovery

- EU-OPENSCREEN ERIC: European Infrastructure of Open Screening Platforms for Chemical Biology

- CIF: Industrial Campus

- I2D2: Innovation Incubation for Drug Discovery

Main USC collaborators

- Dr. Miguel Fidalgo & Dra. Diana Guallar: Stem Cells and Human Diseases

- Dr. Anxo Vidal: Cell Cycle and Oncology

- Dr. Juan Zalvide & Dra. Celia Pombo: Vascular Biology

- Dra. Mabel Loza: BioFarma

- Dr. Angel Carracedo: Genomic Medicine

- Dr. Fernando Dominguez (former PhD supervisor): Galician Group of Oncological Research